Board of Directors

The Board of Directors consists of six external members elected by the shareholders at the Annual General Meeting for terms of one year. Retiring members are eligible for re-election.

The Board is composed of members with personal direct experience from the management of major companies which develop, manufacture and market their products and services globally. Specific competences of the members are:

  • General management
  • International pharma / healthcare experience
  • Pharma R&D and Regulatory management
  • Global manufacturing & logistics
  • Financial management
  • M&A or alliance experience

Target figure for the underrepresented gender in the Board

bluedot

Members of the Board

board - asger Asger Aamund
Chairman of the Board
Info
board - claus Claus Bræstrup
Member of the board since 2008
Info
board - erik Erik G. Hansen
Member of the Board since 2010
Info
board - peter Peter Kürstein
Member of the Board since 2012
Info
board - gerard Gerard van Odijk
Member of the board since 2008
Info
board - anders Anders Gersel Pedersen
Member of the Board since 2010
Info